Correlation Between Hepion Pharmaceuticals and Cidara Therapeutics
Can any of the company-specific risk be diversified away by investing in both Hepion Pharmaceuticals and Cidara Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Hepion Pharmaceuticals and Cidara Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Hepion Pharmaceuticals and Cidara Therapeutics, you can compare the effects of market volatilities on Hepion Pharmaceuticals and Cidara Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Hepion Pharmaceuticals with a short position of Cidara Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Hepion Pharmaceuticals and Cidara Therapeutics.
Diversification Opportunities for Hepion Pharmaceuticals and Cidara Therapeutics
-0.11 | Correlation Coefficient |
Good diversification
The 3 months correlation between Hepion and Cidara is -0.11. Overlapping area represents the amount of risk that can be diversified away by holding Hepion Pharmaceuticals and Cidara Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cidara Therapeutics and Hepion Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Hepion Pharmaceuticals are associated (or correlated) with Cidara Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cidara Therapeutics has no effect on the direction of Hepion Pharmaceuticals i.e., Hepion Pharmaceuticals and Cidara Therapeutics go up and down completely randomly.
Pair Corralation between Hepion Pharmaceuticals and Cidara Therapeutics
Given the investment horizon of 90 days Hepion Pharmaceuticals is expected to under-perform the Cidara Therapeutics. In addition to that, Hepion Pharmaceuticals is 3.92 times more volatile than Cidara Therapeutics. It trades about -0.19 of its total potential returns per unit of risk. Cidara Therapeutics is currently generating about -0.13 per unit of volatility. If you would invest 2,488 in Cidara Therapeutics on November 9, 2024 and sell it today you would lose (365.00) from holding Cidara Therapeutics or give up 14.67% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Hepion Pharmaceuticals vs. Cidara Therapeutics
Performance |
| Timeline |
| Hepion Pharmaceuticals |
| Cidara Therapeutics |
Hepion Pharmaceuticals and Cidara Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Hepion Pharmaceuticals and Cidara Therapeutics
The main advantage of trading using opposite Hepion Pharmaceuticals and Cidara Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Hepion Pharmaceuticals position performs unexpectedly, Cidara Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cidara Therapeutics will offset losses from the drop in Cidara Therapeutics' long position.| Hepion Pharmaceuticals vs. Enveric Biosciences | Hepion Pharmaceuticals vs. Elevation Oncology | Hepion Pharmaceuticals vs. Ocean Biomedical | Hepion Pharmaceuticals vs. Zura Bio Limited |
| Cidara Therapeutics vs. CytomX Therapeutics | Cidara Therapeutics vs. Clearside Biomedical | Cidara Therapeutics vs. GlycoMimetics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Other Complementary Tools
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume |